Terumo (OTCMKTS:TRUMY) Shares Cross Below 50-Day Moving Average – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $14.75 and traded as low as $13.50. Terumo shares last traded at $13.67, with a volume of 228,682 shares changing hands.

Terumo Price Performance

The company has a debt-to-equity ratio of 0.07, a current ratio of 2.51 and a quick ratio of 1.46. The stock has a market capitalization of $20.24 billion, a price-to-earnings ratio of 22.78 and a beta of 0.75. The stock has a 50 day moving average price of $14.75 and a 200-day moving average price of $16.25.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Terumo had a return on equity of 9.39% and a net margin of 12.35%.The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.75 billion.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.